These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12722409)

  • 61. Treatment of benign breast disease with bromocriptine.
    Mussa A; Dogliotti L
    J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Postpartum ovarian physiology. Pituitary gonadotropins, estradiol and prolactin during 12 months of postpartum physiology].
    Hernández Horta JL; Alonso Uriarte Q; Cortés Gallegos V
    Ginecol Obstet Mex; 1994 Jun; 62():171-4. PubMed ID: 8056364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sex hormone changes underlying menstrual disturbances on haemodialysis.
    Wass VJ; Wass JA; Rees L; Edwards CR; Ogg CS
    Proc Eur Dial Transplant Assoc; 1978; 15():178-86. PubMed ID: 368772
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prolactin and breast cancer risk.
    Ingram DM; Nottage EM; Roberts AN
    Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The gonadotropin, prolactin and sex steroid content of the blood from the inferior cavernous sinuses and the adrenal and ovarian veins of women with Itsenko-Cushing disease].
    Manusharova RA; Komissarenko IV; Iugrinov OG
    Vrach Delo; 1991 Mar; (3):71-4. PubMed ID: 2042357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endogenous estrogen modulates phenothiazine stimulated prolactin secretion.
    Buckman MT; Peake GT; Srivastava LS
    J Clin Endocrinol Metab; 1976 Oct; 43(4):901-6. PubMed ID: 977726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Adjuvant pharmacologic therapy after fine needle aspiration of breast cysts in women].
    Wypych K; Kuźlik R; Wypych P
    Ginekol Pol; 2002 Nov; 73(11):1126-31. PubMed ID: 12722410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum hormonal profile in women with congenital uterovaginal absence.
    Kotarski J; Jakowicki J
    Ginekol Pol; 1984 Oct; 55(10):777-81. PubMed ID: 6534808
    [No Abstract]   [Full Text] [Related]  

  • 70. Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease.
    Rose DP; Lahti H; Laakso K; Kettunen K; Wynder EL
    Cancer; 1986 Apr; 57(8):1550-4. PubMed ID: 2418944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Prolactin levels and indicators of breast cancer risk in women with mastopathy].
    Teter J; Paszko Z; Gadomska H; Mach S; Kwiatkowska E
    Nowotwory; 1982; 32(4):193-200. PubMed ID: 7186116
    [No Abstract]   [Full Text] [Related]  

  • 72. Different immunoreactivity between cyst fluid and serum prolactin in women with cystic breast disease.
    Allende MT; Vizoso F; Mosquera E; Fernández Fernández M; Fernández Llana B; Ruibal A
    Int J Biol Markers; 1991; 6(3):199-200. PubMed ID: 1791316
    [No Abstract]   [Full Text] [Related]  

  • 73. Mastodynia due to fibrocystic disease of the breast controlled with thyroid hormone.
    Estes NC
    Am J Surg; 1981 Dec; 142(6):764-6. PubMed ID: 7316045
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy.
    Vizoso F; Allende MT; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(1):33-4. PubMed ID: 1856515
    [No Abstract]   [Full Text] [Related]  

  • 75. [Comparison of ultrasonographic results of the breast with progesterone levels in women with fibrocystic mastopathy].
    Urbanowicz Z; Buchacz P; Poreba R; Noras K
    Ginekol Pol; 1996 Aug; 67(8):411-3. PubMed ID: 9139011
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating blood levels of gonadotropins and prolactin in the normal menstrual cycle.
    Dada OA; Ladipo OA; Osinusi BO; Osotimehin BO; Nduka EU
    Int J Gynaecol Obstet; 1981 Aug; 19(4):291-4. PubMed ID: 6119256
    [No Abstract]   [Full Text] [Related]  

  • 77. Mammary Fibrocystic Change in a Pre-Pubertal child- A Case Report with a Histopathological Perspective.
    Singh S; Gaur K; Puri A
    Fetal Pediatr Pathol; 2021 Oct; 40(5):535-539. PubMed ID: 32075463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Benign breast diseases.
    Courtillot C; Plu-Bureau G; Binart N; Balleyguier C; Sigal-Zafrani B; Goffin V; Kuttenn F; Kelly PA; Touraine P
    J Mammary Gland Biol Neoplasia; 2005 Oct; 10(4):325-35. PubMed ID: 16900392
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic disease.
    Vizoso F; Allende MT; Fernàndez R; Suarez B; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(3):197-8. PubMed ID: 1791315
    [No Abstract]   [Full Text] [Related]  

  • 80. The endocrine basis of benign breast disorders.
    Dogliotti L; Orlandi F; Angeli A
    World J Surg; 1989; 13(6):674-9. PubMed ID: 2696218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.